Oppenheimer Maintains Outperform on ESAB, Lowers Price Target to $135

Benzinga Newsdesk www.benzinga.com Negative 89.0%

Neg 89% Neu 0% Pos 0%

Oppenheimer analyst Bryan Blair maintains ESAB (NYSE:ESAB) with a Outperform and lowers the price target from $140 to $135.